Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2ph5Iky
via IFTTT